PMC4535008_01
Initial EKG (A) shows ST segment elevation in the precordial leads and further change 2 days later (B).
kjim-5-2-112-7f1.jpg
PMC4535008_01_kjim-5-2-112-7f1.jpg
f1-kjim-5-2-112-7
On the fifth day of chemotherpay, she was admitted with intractable nausea, vomiting, dehydration, and an EKG showing an ST elevation in the precordial leads (Fig. 1A). ST-elevation in the percordial leads (Fig. 1B). Serial cardiac enzyme stayed within normal limits.
PMC4535008_02
Prechemotherapy EKG (A) and EKG at the time of chest pain (B) which shows ST segment elevation and T wave inversion precordially, and EKG 3 months later (C) which shows persistent ST-T changes.
kjim-5-2-112-7f2.jpg
PMC4535008_02_kjim-5-2-112-7f2.jpg
f2-kjim-5-2-112-7
At that time the patient had an unremarkable EKG (Fig. 2A). The EKG showed an ST segment elevation in the precordial leads (Fig. 2B). The EKG remained abnormal with an ST-elevation and T-wave inversion for 3 months, at which time the EKG showed only non-specific changes of ST-T segment (Fig. 2C).
PMC4535008_03
Prechemotherapy EKG (A) and EKG during chemotherapy (B) which shows ST elevation in leads II and III and ST depression in the precordial leads.
kjim-5-2-112-7f3.jpg
PMC4535008_03_kjim-5-2-112-7f3.jpg
f3-kjim-5-2-112-7
Pre-treatment EKG was normal (Fig. 3A). The EKG showed sinus tachycardia with ST segment depression in the lateral precordial leads (Fig. 3B).